Sale!

CJC-1295 and Ipamorelin Stack

 Selling fast! Get yours today  Same-day shipping available

Original price was: $144.99.Current price is: $128.99.

In stock

Why this stack

Key highlights

Two 5 mg lyophilized vialsOne vial each of CJC-1295 DAC and Ipamorelin, freeze-dried in sterile, UV-resistant glass vials.
98%+ HPLC purity, bothEach peptide independently analyzed by an accredited US third-party lab.
Cold-chain peptidesRefrigerate after reconstitution. Diluent and lab supplies not included.
Research use onlySupplied exclusively for laboratory investigation and development.
Technical data

Product specifications

CJC-1295 DAC — 5 mg lyophilized
Compound ClassSynthetic Polypeptide · Long-acting GHRH analog (with Drug Affinity Complex, DAC) · GHRH Receptor Agonist
FormLyophilized powder in sterile glass vial
Quantity5 mg per vial
CAS Number863288-34-0
Chemical FormulaC152H252N44O42
Molar Mass3367.9 g/mol
Half-Life~6–8 days
Amino Acid SequenceTyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys
SynonymsCJC-1295 DAC, CJC-1295 with DAC, mod GRF(1-29) + DAC
Verified PurityBatch-tested to 98.96% (HPLC)
Ipamorelin — 5 mg lyophilized
Compound ClassSynthetic Pentapeptide · Selective Growth Hormone Secretagogue · Ghrelin Receptor (GHS-R1a) Agonist
FormLyophilized powder in sterile glass vial
Quantity5 mg per vial
CAS Number170851-70-4
Chemical FormulaC38H49N9O5
Molar Mass711.85 g/mol
Half-Life~2 hours
Amino Acid SequenceAib-His-D-2-Nal-D-Phe-Lys-NH2
SynonymsIpamorelin, NNC 26-0161
Verified PurityBatch-tested to 99.74% (HPLC)

For laboratory research use only. Not for human or animal consumption.

View certificates of analysis
Sourcing & quality

Why source this stack from Sports Technology Labs

Quality control across the research-peptide industry is inconsistent, and many suppliers do not publish third-party testing for their products. Independent verification of identity and purity is essential for reproducible research.

Third-party tested & certified

Both peptides verified by MZ Biolabs (Tucson, AZ), an accredited US laboratory, via HPLC and mass spectrometry, with batch-linked COAs.

Lyophilized & packaged in America

Freeze-dried into sterile, UV-resistant glass vials and packaged in the USA.

Tamper-evident packaging

Supports chain-of-custody, label transparency, and batch-linked traceability.

60-day money-back guarantee

Transparent business, standard payment methods, no misrepresentation.

Research context

What is in this stack?

This stack pairs two research peptides that act on the growth-hormone axis through different receptors — CJC-1295 DAC and Ipamorelin — supplied as separate lyophilized vials. The two are described below by identity only.

Component 1

CJC-1295 DAC

CJC-1295 DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) — a modified GRF(1–29) peptide bearing a Drug Affinity Complex (DAC), a lysine-linked moiety that binds serum albumin to extend the molecule’s circulating half-life. Mechanistically, it is a GHRH-receptor agonist. It is used as a research chemical to investigate GHRH-receptor signaling in experimental models.

Component 2

Ipamorelin

Ipamorelin is a synthetic pentapeptide characterized in the literature as the first selective growth hormone secretagogue. It acts as an agonist of the growth hormone secretagogue receptor (GHS-R1a), the receptor for the endogenous peptide ghrelin. It is used as a research chemical to investigate GHS-R1a signaling in experimental models.

These compounds are supplied strictly as research chemicals for laboratory research. Sports Technology Labs makes no claims regarding their effects, and nothing in this listing should be interpreted as describing outcomes in humans or animals.

Regulatory & compliance status

Important regulatory information

Not approved for human use

Both peptides are investigational research chemicals. They are not approved by the FDA and are not drugs, foods, dietary supplements, or cosmetics. Marketing them for human use is unlawful.

WADA status — CJC-1295 DAC

Growth hormone-releasing hormone (GHRH) and its analogues are prohibited by the World Anti-Doping Agency at all times under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics) (ref. 4).

WADA status — Ipamorelin

Growth hormone secretagogues, including GH-releasing peptides such as ipamorelin, are prohibited by the World Anti-Doping Agency at all times under S2 (ref. 4).

Our position

Sports Technology Labs are chemical suppliers, not medical providers. We do not condone or encourage consumer use of research compounds.

Citations

Scientific references

  1. Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin is the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552–561.
  2. National Center for Biotechnology Information. PubChem Compound Summary for CJC-1295 (CAS 863288-34-0): sequence, molecular formula, and molecular weight. PubChem, National Library of Medicine.
  3. National Center for Biotechnology Information. PubChem Compound Summary for Ipamorelin (CAS 170851-70-4): sequence, molecular formula, and molecular weight. PubChem, National Library of Medicine.
  4. WADA Prohibited List (2025), Section S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics (GHRH and analogues; Growth Hormone Secretagogues / GHRPs). WADA.org.

Research use only. All products on this website are intended exclusively for laboratory research and development. They are not for human or animal consumption. These statements have not been evaluated by the U.S. Food and Drug Administration, and these products are not intended to diagnose, treat, cure, or prevent any disease.

Additional information

Weight 4 oz
Dimensions 4 × 2 × 2 in

Third-party verified by MZ Biolabs (Tucson, AZ), a US DEA Schedule III licensed facility (License: RP0584676). Every batch undergoes rigorous HPLC purity analysis and Mass Spectrometry identity confirmation under Good Laboratory Practice (GLP) standards to ensure purity and research reproducibility.

CJC-1295 with DAC

  • Date07/03/25
  • Purity Level: 98.96%

STL CJC 1295 COA 7.3.25

Ipamorelin

  • Date: 03/31/25
  • Purity Level: 99.74%

STL COA_Ipamorelin

View all COAs at the bottom of this tab.

Mechanism of Action:

Ipamorelin is a pentapeptide known for its ability to stimulate the pituitary gland to release growth hormone. It operates by interacting with growth hormone secretagogue receptors, triggering a cascade of biological events leading to elevated growth hormone levels. Ipamorelin is classified as a Growth Hormone-Releasing Peptide (GHRP), recognized for its capacity to increase levels of growth hormone.

Selective Effects:

Ipamorelin exerts its effects primarily on growth hormone release, with minimal impact on other hormones such as thyroid-stimulating hormone, luteinizing hormone, and prolactin.

Ipamorelin Product Specifications:

CAS Number: 170851-70-4

Formula: C38H49N9O5

Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2

Molar Mass: 711.85 g/mol

Half-life: 2 hours

Class: Peptide

SKU: 54

Storage: Keep refrigerated upon reconstitution.

  • Lyophilized sample in a sterile glass vial.
  • Minimum 99% pure.
  • 5 mg Ipamorelin per vial.
  • Diluent and laboratory supplies are not included.

Mechanism of Action:

CJC-1295 mimics natural Growth Hormone-Releasing Hormone (GHRH) in the body, effectively binding to growth hormone-releasing hormone receptors in the anterior pituitary gland. This interaction stimulates the production and release of growth hormones into systemic circulation, leading to sustained increased levels for an extended period.

Extended Half-life:

CJC-1295 boasts a prolonged duration of action compared to conventional peptides, thanks to the inclusion of Drug Affinity Complex (DAC), which extends stability and ensures sustained stimulation of growth hormone production.

CJC-1295 DAC Specifications:

CAS Number: 863288-34-0

Formula: C152H252N44O42

Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala- Arg-Lys-LeuLeu-Gln-Asp-Ile-Leu-Ser-Arg-Lys

Molar Mass: 3367.9 g/mol

Half-life: 6-8 days

Class: Peptide

Storage: Keep refrigerated upon reconstitution.

  • Lyophilized sample in a sterile glass vial.
  • Minimum 99% pure.
  • 5 mg CJC-1295 DAC per vial.
  • Diluent and laboratory supplies are not included.

Scientific References:

1. Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH. Ipamorelin is the first selective growth hormone secretagogue. Eur J Endocrinol. 1998 Nov;139(5):552-61. Doi: 10.1530/eje.0.1390552. PMID: 9849822.

2. Aagaard NK, Grøfte T, Greisen J, Malmlöf K, Johansen PB, Grønbaek H, Ørskov H, Tygstrup N, Vilstrup H. Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid-treated rats. Growth Horm IGF Res. 2009 Oct;19(5):426-31. doi: 10.1016/j.ghir.2009.01.001. Epub 2009 Feb 23. PMID: 19231263.

3. Andersen NB, Malmlöf K, Johansen PB, Andreassen TT, Ørtoft G, Oxlund H. The growth hormone secretagogue ipamorelin counteracts the glucocorticoid-induced decrease in bone formation of adult rats. Growth Horm IGF Res. 2001 Oct;11(5):266-72. doi: 10.1054/ghir. 2001.0239. PMID: 11735244.

4. Svensson J, Lall S, Dickson SL, Bengtsson BA, Rømer J, Ahnfelt-Rønne I, Ohlsson C, Jansson JO. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. J Endocrinol. 2000 Jun;165(3):569-77. doi: 10.1677/joe. 0.1650569. PMID: 10828840.

5. Adeghate E, Ponery AS. Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic rats. Neuro Endocrinol Lett. 2004 Dec;25(6):403-6. PMID: 15665799.

6. Fowkes MM, Lalonde T, Yu L, Dhanvantari S, Kovacs MS, Luyt LG. Peptidomimetic growth hormone secretagogue derivatives for positron emission tomography imaging of the ghrelin receptor. Eur J Med Chem. 2018 Sep 5;157:1500-1511. doi: 10.1016/j.ejmech.2018.08.062. Epub 2018 Aug 23. PMID: 30282322.

7. Beck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014 Dec;29(12):1527-34. doi: 10.1007/s00384-014-2030-8. Epub 2014 Oct 21. PMID: 25331030.

8. Greenwood-Van Meerveld B, Tyler K, Mohammadi E, Pietra C. Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus. J Exp Pharmacol. 2012 Oct 19;4:149-55. doi: 10.2147/JEP.S35396. PMID: 27186127; PMCID: PMC4863553.

9. Ipamorelin Peptide: Exploring Its Potential in Growth Hormone Stimulation and Health. Peptide Information (2023).

10. Sackmann-Sala, L., Ding, J., Frohman, L. A., & Kopchick, J. J. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Hormone & IGF Research19(6), 471-477.

11. Knoop, A., Thomas, A., Fichant, E., Delahaut, P., Schänzer, W., & Thevis, M. (2016). Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. Analytical and Bioanalytical Chemistry408, 3145-3153.

12. Van Hout, M. C., & Hearne, E. (2016). Netnography of female use of the synthetic growth hormone CJC-1295: pulses and potions. Substance Use & Misuse51(1), 73-84.

13. Alba, M., Fintini, D., Sagazio, A., Lawrence, B., Castaigne, J. P., Frohman, L. A., & Salvatori, R. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American Journal of Physiology-Endocrinology and Metabolism291(6), E1290-E1294.

14. McDonald J, Lambert DG. Drug-receptor interactions in anaesthesia. BJA Educ. 2022 Jan;22(1):20-25. doi: 10.1016/j.bjae.2021.07.009. Epub 2021 Oct 14. PMID: 34992797; PMCID: PMC8703152.

You may also like…